Commerce Bank Acquires Shares of 11,842 Ventas, Inc. $VTR

Commerce Bank acquired a new stake in Ventas, Inc. (NYSE:VTR) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 11,842 shares of the real estate investment trust’s stock, valued at approximately $1,052,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Ventas during the 2nd quarter valued at approximately $4,953,439,000. Capital World Investors bought a new stake in Ventas in the fourth quarter worth $594,116,000. Norges Bank bought a new stake in Ventas in the fourth quarter worth $474,571,000. Deutsche Bank AG purchased a new position in Ventas during the second quarter worth $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Ventas by 32,509.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after buying an additional 4,634,520 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Down 0.1%

Shares of NYSE:VTR opened at $93.73 on Thursday. The business’s 50 day moving average is $91.99 and its 200 day moving average is $87.47. The stock has a market cap of $48.08 billion, a P/E ratio of 173.57, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. Ventas, Inc. has a 52-week low of $66.38 and a 52-week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR) last issued its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. The business had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.Ventas’s revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.87 EPS. Sell-side analysts predict that Ventas, Inc. will post 3.89 EPS for the current year.

Insider Activity at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.53% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Scotiabank reduced their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Jefferies Financial Group raised their target price on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Citigroup lifted their price target on shares of Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Finally, Royal Bank Of Canada increased their price objective on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and an average price target of $98.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.